Researchers find that most common drugs may cause lasting gut microbiome changes, highlighting the need for mindful medication and diet choices.
Sam’s Club launches $499 pricing for Ozempic and Wegovy, expanding access to weight-loss meds and same-day delivery for refrigerated prescriptions.
A new study reveals COVID boosters cut deaths by 64% and hospitalizations by 39%, offering protection across all age groups…
A VA study shows Covid vaccines reduce deaths by 64%, proving especially vital for those over 65 while offering modest…
AlphaMedix™ achieved major success in a phase 2 GEP-NET cancer trial, marking a breakthrough in targeted alpha therapy for advanced…
A new study reveals tramadol provides limited relief and higher risks, challenging its role as a safe opioid for managing…
FDA warns of growing risks from gray-market GLP-1 drugs as unregulated Ozempic and Wegovy alternatives raise safety and counterfeit concerns.
AstraZeneca partners with Algen Biotech in a $555M AI and CRISPR deal to accelerate immunology drug discovery using Algen’s advanced…
Skye Bioscience shares sank 60% as its drug nimacimab missed weight-loss goals, though combo data with semaglutide hinted at potential…
AstraZeneca and Daiichi Sankyo’s Datroway achieved major success in a late-stage trial, offering new hope for patients with triple-negative breast…
Caffeine can impact how certain medications work. Discover safe timing tips to enjoy coffee without compromising your treatment’s effectiveness.
President Trump introduces TrumpRX, a direct-to-consumer platform aimed at lowering prescription drug costs and improving medication access nationwide.
GLP-1 drugs show promise in lowering cancer risks for women, while also improving obesity, fertility, and overall health outcomes.
Sign in to your account